These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20196954)
1. [Characteristics of peripheral NK cells in hepatocellular carcinoma patients]. Zhou L; Cai L; Zhang Z; Yang YP; Wang FS Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):136-9. PubMed ID: 20196954 [TBL] [Abstract][Full Text] [Related]
2. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414 [TBL] [Abstract][Full Text] [Related]
5. Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma. Fathy A; Eldin MM; Metwally L; Eida M; Abdel-Rehim M Egypt J Immunol; 2009; 16(2):17-25. PubMed ID: 22059350 [TBL] [Abstract][Full Text] [Related]
6. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis. Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369 [TBL] [Abstract][Full Text] [Related]
7. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma. Yuen MF; Norris S Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217 [TBL] [Abstract][Full Text] [Related]
8. [Changes and clinical significance of peripheral blood natural killer cells in neonates with bacterial pneumonia]. Li Q; Weng K; Zhu L; Mei X; Xu L; Lin J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1067-70. PubMed ID: 25270210 [TBL] [Abstract][Full Text] [Related]
9. Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells. Hu J; Wang E; Liu L; Wang Q; Xia D; Bai W; Tie J; Li X; Yuan J; Yang S; Jiang D; Shi J; Sun Y; Wang J; Zhang C; Niu J; Li K; He C; Guo W; Lv Y; Chen H; Yuan X; Yu T; Wang Z; Luo B; Han N; Zhu Y; Yin Z; Fan D; Zhang Z; Yang K; Han G Invest New Drugs; 2020 Oct; 38(5):1247-1256. PubMed ID: 31832851 [TBL] [Abstract][Full Text] [Related]
10. The correlation between the percent of CD3- CD56+ cells and NK precursor function. Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495 [TBL] [Abstract][Full Text] [Related]
12. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells. Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634 [TBL] [Abstract][Full Text] [Related]
13. Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α. Riley CH; Hansen M; Brimnes MK; Hasselbalch HC; Bjerrum OW; Straten PT; Svane IM; Jensen MK Eur J Haematol; 2015 Mar; 94(3):227-34. PubMed ID: 25082025 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732 [TBL] [Abstract][Full Text] [Related]
15. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia]. Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of Human Hepatic Intrasinusoidal CD56 Hwang S; Han J; Baek JS; Tak E; Song GW; Lee SG; Jung DH; Park GC; Ahn CS; Kim N Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925759 [TBL] [Abstract][Full Text] [Related]
17. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection. Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004 [TBL] [Abstract][Full Text] [Related]
18. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416 [TBL] [Abstract][Full Text] [Related]
19. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870 [TBL] [Abstract][Full Text] [Related]
20. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Gaddy J; Broxmeyer HE Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]